您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > Hcyb1
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Hcyb1
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
包装与价格:
包装价格(元)
50 mg电议
100 mg电议

产品介绍
Hcyb1 是一种高度选择性的PDE2抑制剂。Hcyb1 对PDE2A具有高度选择性抑制作用 (IC50=0.57 μM),比作用于其他 PDE 家族成员的选择性高 250 多倍。Hcyb1 具有神经保护和抗抑郁作用。

产品描述

Hcyb1 is a highly selective PDE2 inhibitor. Hcyb1 has a highly selective inhibition of PDE2A ( IC 50 =0.57 μM) and over 250-fold selectivity against other recombinant PDE family members. Hcyb1 produces neuroprotective and antidepressant‐like effects most likely mediated by cAMP/cGMP-CREB-BDNF signaling [1].

体外活性

Hcyb1 increases cGMP levels by 1.7~2.3 folds after 10-minute treatment at concentrations of 1~100 nM [1]. Hcyb1 increases both cGMP and cAMP levels 24 hours after treatment at the concentrations of 1 nM [1]. Hcyb1 treatment also increases the levels of phosphorylation of CREB and BDNF in HT-22 cells for 24 hours [1]. Hcyb1 promotes HT-22 cell viability and increase the cGMP and cAMP accumulation in HT-22 cells [1]. Hcyb1 exhibits the concentration- and time-dependent effects on cell viability in HT-22 cells [2]. Cell Proliferation Assay [1] Cell Line: HT-22 cells Concentration: 1 pM, 0.01 nM, 0.1 nM, 1 nM, 0.01 μM, 0.1 μM, 1 μM, 10 μM Incubation Time: 24 hours Result: The cell viability was significantly increased when treatment HT-22 cells with Hcyb1 at concentrations of 0.1 nM and 1 nM for 24 hours. The time-dependent effects showed that the cell viability was significantly increased from 12 to 24 hours when treatment at concentration of 1 nM. The maximal effects peaked at 24 hours after treatment. Western Blot Analysis [1] Cell Line: HT-22 cells Concentration: 1 nM Incubation Time: 24 hours Result: Induced a significant increase in the phosphorylation of CREB. BDNF expression was also significantly upregulated at the same concentration.

体内活性

Hcyb1 (0.5, 1, and 2 mg/kg, i.g.) decreases the immobility time in both forced swimming and tail suspension tests, without altering locomotor activity [3]. Animal Model: Male imprinting control region (ICR) mice, weighing between 20 and 25 g [3] Dosage: 0.5, 1, and 2 mg/kg Administration: Gavage (i.g.) Result: Exhibited dose-dependent reduction in immobility time at doses of 0.5, 1, 2 mg/kg (i.g.).

分子式

C24H20N4O

分子量

380.44

储存和溶解度

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years